In addition, our findings suggest that decreasing serum FGF‐23 concentrations might be useful in preventing the development of hyperphosphatemia, but we cannot conclude that therapeutic intervention based on increased FGF‐23 concentration in dogs with CKD is beneficial because of the retrospective study design. The gene discussed is FGF23; the disease is hyperphosphatemia.